|Bid||0.0000 x 800|
|Ask||0.0000 x 900|
|Day's range||4.4000 - 4.7100|
|52-week range||3.4600 - 27.1800|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||44.23|
|Earnings date||09 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||6.07|
Investors need to pay close attention to InnovAge (INNV) stock based on the movements in the options market lately.
By Dhirendra Tripathi
InnovAge (NASDAQ: INNV) is one company that will be very glad to see 2021 consigned to the history books. On Monday, the company's stock fell by 11%, on the back of two recommendation downgrades from prominent investment banks. The catalyst for the downgrades was InnovAge's disclosure last week that it had been hit with sanctions from the Centers for Medicare and Medicaid Services (CMS).